201 related articles for article (PubMed ID: 17121920)
21. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
22. Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4.
Ahn DS; Lee HJ; Hwang J; Han H; Kim B; Shim B; Kim SH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772677
[TBL] [Abstract][Full Text] [Related]
23. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
24. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps.
Danish L; Imig D; Allgöwer F; Scheurich P; Pollak N
PLoS One; 2018; 13(6):e0198203. PubMed ID: 29927992
[TBL] [Abstract][Full Text] [Related]
26. The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells.
Cai J; Wang D; Bai ZG; Yin J; Zhang J; Zhang ZT
PLoS One; 2017; 12(8):e0182433. PubMed ID: 28792527
[TBL] [Abstract][Full Text] [Related]
27. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.
Shrader M; Pino MS; Lashinger L; Bar-Eli M; Adam L; Dinney CP; McConkey DJ
Cancer Res; 2007 Feb; 67(4):1430-5. PubMed ID: 17308080
[TBL] [Abstract][Full Text] [Related]
28. Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
Strekalova E; Malin D; Rajanala H; Cryns VL
Breast Cancer Res Treat; 2017 Jun; 163(3):435-447. PubMed ID: 28324269
[TBL] [Abstract][Full Text] [Related]
29. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.
Jung KJ; Min KJ; Bae JH; Kwon TK
Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy.
Xu J; Zhou JY; Wu GS
Cancer Res; 2006 Oct; 66(20):10092-9. PubMed ID: 17047073
[TBL] [Abstract][Full Text] [Related]
31. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of p53-mediated transcriptional responses by mithramycin A.
Koutsodontis G; Kardassis D
Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma.
Seznec J; Silkenstedt B; Naumann U
J Neurooncol; 2011 Feb; 101(3):365-77. PubMed ID: 20556479
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
Fulda S; Meyer E; Debatin KM
Oncogene; 2002 Apr; 21(15):2283-94. PubMed ID: 11948412
[TBL] [Abstract][Full Text] [Related]
35. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.
Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N
Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781
[TBL] [Abstract][Full Text] [Related]
36. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
37. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx.
Moon DO; Kang CH; Kang SH; Choi YH; Hyun JW; Chang WY; Kang HK; Koh YS; Maeng YH; Kim YR; Kim GY
Toxicol Appl Pharmacol; 2012 Feb; 259(1):87-95. PubMed ID: 22200406
[TBL] [Abstract][Full Text] [Related]
38. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP.
Thayaparasingham B; Kunz A; Peters N; Kulms D
Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816
[TBL] [Abstract][Full Text] [Related]
39. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
Lee JT; Lee TJ; Park JW; Kwon TK
Int J Oncol; 2009 May; 34(5):1455-60. PubMed ID: 19360359
[TBL] [Abstract][Full Text] [Related]
40. Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
Kim EH; Kim SU; Choi KS
Oncogene; 2005 Jan; 24(5):838-49. PubMed ID: 15531913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
